Header Logo

Connection

Ira Targoff to Adolescent

This is a "connection" page, showing publications Ira Targoff has written about Adolescent.
Connection Strength

0.270
  1. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies. Arthritis Res Ther. 2020 04 06; 22(1):69.
    View in: PubMed
    Score: 0.026
  2. Long-term outcomes in Juvenile Myositis patients. Semin Arthritis Rheum. 2020 02; 50(1):149-155.
    View in: PubMed
    Score: 0.024
  3. Medications received by patients with juvenile dermatomyositis. Semin Arthritis Rheum. 2018 12; 48(3):513-522.
    View in: PubMed
    Score: 0.022
  4. Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients. Arthritis Care Res (Hoboken). 2017 07; 69(7):1088-1094.
    View in: PubMed
    Score: 0.021
  5. Monitoring change in volume of calcifications in juvenile idiopathic inflammatory myopathy: a pilot study using low dose computed tomography. Pediatr Rheumatol Online J. 2016 Nov 29; 14(1):64.
    View in: PubMed
    Score: 0.020
  6. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Medicine (Baltimore). 2014 Nov; 93(24):318-332.
    View in: PubMed
    Score: 0.018
  7. Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken). 2014 May; 66(5):732-40.
    View in: PubMed
    Score: 0.017
  8. Clinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophy. Arthritis Care Res (Hoboken). 2013 Dec; 65(12):1969-75.
    View in: PubMed
    Score: 0.017
  9. Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis. Arthritis Rheum. 2013 Jul; 65(7):1934-41.
    View in: PubMed
    Score: 0.016
  10. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore). 2013 Jul; 92(4):223-243.
    View in: PubMed
    Score: 0.016
  11. Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies. Arthritis Rheum. 2008 Oct; 58(10):3239-46.
    View in: PubMed
    Score: 0.012
  12. Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine (Baltimore). 2008 Mar; 87(2):70-86.
    View in: PubMed
    Score: 0.011
  13. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther. 2007; 9(4):R78.
    View in: PubMed
    Score: 0.010
  14. HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum. 2006 Nov; 54(11):3670-81.
    View in: PubMed
    Score: 0.010
  15. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore). 2005 Jul; 84(4):231-249.
    View in: PubMed
    Score: 0.009
  16. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy. Arthritis Rheum. 1998 Apr; 41(4):710-9.
    View in: PubMed
    Score: 0.006
  17. Clinical significance of specific autoantibodies in juvenile dermatomyositis. J Rheumatol. 1996 Oct; 23(10):1794-7.
    View in: PubMed
    Score: 0.005
  18. Pulmonary fibrosis and myositis in a child with anti-Jo-1 antibody. J Rheumatol. 1995 Apr; 22(4):762-5.
    View in: PubMed
    Score: 0.005
  19. A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children. Arthritis Rheum. 1994 Oct; 37(10):1534-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.